Found: 89
Select item for more details and to access through your institution.
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5102, doi. 10.1002/alz.13883
- By:
- Publication type:
- Article
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-00990-0
- By:
- Publication type:
- Article
Fibrillar and Oligomeric β-Amyloid as Distinct Local Biomarkers for Alzheimer's Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1097, p. 239, doi. 10.1196/annals.1379.023
- By:
- Publication type:
- Article
Harmonization of brain PET images in multi-center PET studies using Hoffman phantom scan.
- Published in:
- EJNMMI Physics, 2023, v. 10, n. 1, p. 1, doi. 10.1186/s40658-023-00588-x
- By:
- Publication type:
- Article
Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2020, v. 140, n. 4, p. 463, doi. 10.1007/s00401-020-02175-1
- By:
- Publication type:
- Article
Estimation of amyloid distribution by [<sup>18</sup>F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.
- Published in:
- Acta Neuropathologica, 2018, v. 136, n. 4, p. 557, doi. 10.1007/s00401-018-1897-9
- By:
- Publication type:
- Article
[F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.
- Published in:
- Acta Neuropathologica, 2012, v. 124, n. 6, p. 833, doi. 10.1007/s00401-012-1051-z
- By:
- Publication type:
- Article
Correction to: Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
- Published in:
- Acta Neuropathologica Communications, 2019, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40478-019-0837-9
- By:
- Publication type:
- Article
Prospective Flutemetamol Positron Emission Tomography and Histopathology in Normal Pressure Hydrocephalus.
- Published in:
- Neurodegenerative Diseases, 2014, v. 13, n. 4, p. 237, doi. 10.1159/000355256
- By:
- Publication type:
- Article
Impact of APOE‐ε4 on cerebral amyloid deposition in participants with abnormal soluble amyloid levels: Amyloid imaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045828
- By:
- Publication type:
- Article
Harmonization of amyloid PET scans minimizes the impact of reconstruction parameters on centiloid values: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045294
- By:
- Publication type:
- Article
Weight loss predicts Alzheimer's disease biomarker positivity in cognitively unimpaired middle‐aged adults: Epidemiology: Cardiovascular risk factors.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045137
- By:
- Publication type:
- Article
Multiple biological pathways associate with cerebral amyloid load in the early Alzheimer's continuum: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044733
- By:
- Publication type:
- Article
A multi‐study analysis of the spatial‐temporal progression of amyloid deposition and its utility for longitudinal studies: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044707
- By:
- Publication type:
- Article
Classification of <sup>18</sup>F‐flutemetamol scans using machine learning with neuropathology as standard of truth: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044550
- By:
- Publication type:
- Article
A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [<sup>18</sup>F]flutemetamol PET images: Neuroimaging / Optimal neuroimaging measures for early detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043157
- By:
- Publication type:
- Article
Examining centiloid quantification against visual assessment using [18F]flutemetamol PET: The value of amyloid PET beyond dichotomization.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042653
- By:
- Publication type:
- Article
Baseline features of the AMYPAD Diagnostic and Patient Management Study (DPMS) participants: Neuroimaging / differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042628
- By:
- Publication type:
- Article
Impact of the disclosure of amyloid‐PET results to patients with subjective cognitive decline: the AMYPAD Diagnostic and Patient Management Study (DPMS): Neuroimaging / Normal brain aging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040952
- By:
- Publication type:
- Article
P4‐307: THE ADDED VALUE OF QUANTITATIVE AMYLOID PET IN DETERMINING ALZHEIMER'S DISEASE (AD) DEMENTIA RISK: THE AMYPAD PROGNOSTIC AND NATURAL HISTORY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1408, doi. 10.1016/j.jalz.2019.06.3977
- By:
- Publication type:
- Article
F4‐03‐03: SELECTIVITY OF PET AMYLOID IMAGING LIGANDS IN THE ALZHEIMER'S DISEASE NEUROPATHOLOGY SPECTRUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1222, doi. 10.1016/j.jalz.2019.06.4724
- By:
- Publication type:
- Article
P3‐373: AMYPAD‐DPMS PRELIMINARY RESULTS: PARTICIPANTS' BASELINE FEATURES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1090, doi. 10.1016/j.jalz.2019.06.3406
- By:
- Publication type:
- Article
AMYPAD Diagnostic and Patient Management Study: Rationale and design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 3, p. 388, doi. 10.1016/j.jalz.2018.09.003
- By:
- Publication type:
- Article
IC‐P‐012: CONFOCAL ANALYSIS OF FLUORESCENT SIGNAL DERIVED FROM CN‐FLUTEMETAMOL LABELED DIFFUSE AND NEURITIC PLAQUES IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P21, doi. 10.1016/j.jalz.2018.06.2076
- By:
- Publication type:
- Article
AMYLOID PET UTILITY IN CLINICAL PRACTICE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P398, doi. 10.1016/j.jalz.2017.06.379
- By:
- Publication type:
- Article
DETERMINATION OF NEURITIC VERSUS DIFFUSE PLAQUE CONTRIBUTION TO SIGNAL DERIVED FROM CN-FLUTEMETAMOL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1115, doi. 10.1016/j.jalz.2017.06.1614
- By:
- Publication type:
- Article
DETERMINATION OF NEURITIC VERSUS DIFFUSE PLAQUE CONTRIBUTION TO SIGNAL DERIVED FROM CN-FLUTEMETAMOL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P16, doi. 10.1016/j.jalz.2017.06.2283
- By:
- Publication type:
- Article
THE AMYPAD-DX CONTROLLED TRIAL ON THE DIAGNOSTIC VALUE OF AMYLOID PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1523, doi. 10.1016/j.jalz.2017.07.653
- By:
- Publication type:
- Article
[18F]FLUTEMETAMOL AMYLOID SCANNING IN A PHASE III AMNESTIC MILD COGNITIVE IMPAIRMENT STUDY: ADDITIONAL INFLUENCE OF OTHER BIOMARKERS IN ESTIMATING RISK OF CONVERSION TO PROBABLE ALZHEIMERS DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P221, doi. 10.1016/j.jalz.2017.07.100
- By:
- Publication type:
- Article
METHODOLOGICAL AND LOGISTIC STRATEGIES FOR A LARGE MULTI-CENTER β-AMYLOID PET EUROPEAN PROJECT: AMYLOID IMAGING TO PREVENT ALZHEIMER’S DISEASE (AMYPAD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P794, doi. 10.1016/j.jalz.2017.06.1074
- By:
- Publication type:
- Article
AMYPAD: A EUROPEAN PUBLIC-PRIVATE PARTNERSHIP TO INVESTIGATE THE VALUE OF β-AMYLOID BRAIN SCANS AS A DIAGNOSTIC AND THERAPEUTIC MARKER FOR ALZHEIMER’S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P420, doi. 10.1016/j.jalz.2017.06.411
- By:
- Publication type:
- Article
MEASUREMENT OF PATHOLOGICAL AMYLOID IN ROUTINE CLINICAL ASSESSMENT: THE CLINICAL IMPACT OF VISUAL [18F]FLUTEMETAMOL PET AND CSF ANALYSIS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P411, doi. 10.1016/j.jalz.2017.06.397
- By:
- Publication type:
- Article
PERFORMANCE OF [18F]FLUTEMETAMOL AMYLOID IMAGING AGAINST THE CURRENT (2012) NIA-AA RECOMMENDATIONS FOR THE NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P926, doi. 10.1016/j.jalz.2016.06.1916
- By:
- Publication type:
- Article
Gene-gene interaction and subclinical amyloid levels in cognitively intact elderly individuals
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Comparison of three diagnostic methods for determining amyloid positivity in cognitively intact elderly controls : Flutemetamol in Flander's Aging population (FLUFLAG study)
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Prospective and retrospective evaluation of [18F]Flutemetamol for beta-amyloid detection in the brain of living subjects with normal pressure hydrocephalus
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Flutemetamol F 18 injection PET images reflect brain beta-amyloid levels
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Nuances in [18F] flutemetamol reader methodology: High inter- and intra reader agreement rates
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Support vector machine-based classification of 18F-flutemetamol scans in Alzheimer's disease, MCI and controls: comparison with visual reads and structural MRI-based classification
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Concordance between visual read and quantification for categorisation of [<sup>18</sup>F]Flutemetamol data into either normal or abnormal amyloid levels
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Visual Read Performance and Related Metrics of the Amyloid Imaging Agent [<sup>18</sup>F]flutemetamol; Results from the Phase II Multicenter Trial
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Quantitative Brain Amyloid PET.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.265766
- By:
- Publication type:
- Article
Quantitative Brain Amyloid PET.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 670, doi. 10.2967/jnumed.123.265766
- By:
- Publication type:
- Article
The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.235879
- By:
- Publication type:
- Article
Impact of simulated reduced injected dose on the assessment of amyloid PET scans.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 3, p. 734, doi. 10.1007/s00259-023-06481-0
- By:
- Publication type:
- Article
Clinical outcomes up to 9 years after [<sup>18</sup>F]flutemetamol amyloid-PET in a symptomatic memory clinic population.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01351-1
- By:
- Publication type:
- Article
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
- Published in:
- Acta Neuropathologica Communications, 2016, v. 4, p. 1, doi. 10.1186/s40478-016-0399-z
- By:
- Publication type:
- Article
Author Correction: Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Concordance in detecting amyloid positivity between <sup>18</sup>F-florbetaben and <sup>18</sup>F-flutemetamol amyloid PET using quantitative and qualitative assessments.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-76102-5
- By:
- Publication type:
- Article